Bristol Myers Squibb's immunotherapy Opdivo (nivolumab) has cleared a key hurdle toward expanded reimbursement in Korea for ...
Pfizer Korea said Friday that its tumor necrosis factor (TNF) inhibitor Enbrel (etanercept) has gained national health ...
Cancer medicine is becoming more complex, and the field needs firmer scientific foundations to keep pace, Fabrice André, ...
Kolmar Korea said Friday it became the first Korean cosmetics company invited to Première Vision Paris, as the cosmetics ...
Seoul National University Bundang Hospital (SNUBH) researchers have identified two tailored strategies that could help reduce ...
Curocell’s homegrown chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (anbalcabtagene autoleucel) has cleared ...
Sky Labs surged more than 170 percent above its initial public offering price Friday as the Korean digital healthcare company ...
For most of the last four decades, the rat sarcoma (RAS) gene was the target that humbled cancer drug developers. It is ...
Hanmi Pharmaceutical said Friday it has completed the core treatment period of a global phase 2 trial of efpegerglucagon (HM15136), its once-weekly treatment candidate for congenital hyperinsulinism.T ...
Raziel Therapeutics, a biotech partner of GC Wellbeing, has met key efficacy and safety endpoints in a phase 3 trial in China ...
A multidisciplinary approach combining infection control, blood flow restoration, reconstructive surgery and rehabilitation ...
Hemophilia B has traditionally required lifelong treatment to replace the clotting factor patients cannot produce on their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results